Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer. (Q39108991)
Jump to navigation
Jump to search
scientific article published on 15 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer. |
scientific article published on 15 August 2013 |
Statements
Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer (English)
Yota Yasumizu
Akira Miyajima
Takeo Kosaka
Yasumasa Miyazaki